Litcius/Paper detail

STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC

Anlin Li, Yuanyuan Wang, Zhixin Yu, Zihui Tan, Lina He, Sha Fu, Mengting Shi, Wei Du, Linfeng Luo, Zhichao Li, Jiaqing Liu, Yixin Zhou, Wenfeng Fang, Yunpeng Yang, Li Zhang, Shaodong Hong

2023Journal of Thoracic Oncology45 citationsDOIOpen Access PDF

Topics & Concepts

MedicineStingPhenotypeImmunotherapyInterferonCD8STK11MutationCancer researchCytotoxic T cellStimulator of interferon genesImmunologyInternal medicineGeneGeneticsCancerImmune systemIn vitroBiologyKRASColorectal cancerAerospace engineeringInnate immune systemEngineeringCancer Immunotherapy and Biomarkersinterferon and immune responsesLung Cancer Treatments and Mutations
STK11/LKB1-Deficient Phenotype Rather Than Mutation Diminishes Immunotherapy Efficacy and Represents STING/Type I Interferon/CD8+ T-Cell Dysfunction in NSCLC | Litcius